April 2019 - SYSTEM dosage pharmaceutical drug information and patent profiles

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration	Dosage
Powder Pharms	ZINGO	lidocaine hydrochloride	SYSTEM;INTRADERMAL	022114-001	Aug 16, 2007		RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up	SYSTEM;INTRADERMAL
Powder Pharms	ZINGO	lidocaine hydrochloride	SYSTEM;INTRADERMAL	022114-001	Aug 16, 2007		RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up	SYSTEM;INTRADERMAL
Powder Pharms	ZINGO	lidocaine hydrochloride	SYSTEM;INTRADERMAL	022114-001	Aug 16, 2007		RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up	SYSTEM;INTRADERMAL
Ibsa Inst Bio	LICART	diclofenac epolamine	SYSTEM;TOPICAL	206976-001	Dec 19, 2018		DISCN	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up	SYSTEM;TOPICAL
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013		DISCN	Yes	No	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up	SYSTEM;IONTOPHORESIS
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013		DISCN	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up	SYSTEM;IONTOPHORESIS
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration	Dosage